Beneficial role of vitexin in Parkinsons disease

QR Code

Beneficial role of vitexin in Parkinsons disease

Today, Parkinsons disease (PD) is the foremost neurological disorder all across the globe. In the quest for a novel therapeutic agent for PD with a multimodal mechanism of action and relatively better safety profile, natural flavonoids are now receiving greater attention as a potential source of neu...

Full description

Bibliographic Details
Main Authors:	Mustapha, Musa, Mat taib, Che Norma
Format:	Article
Published:	Penerbit Universiti Sains Malaysia, Universiti Sains Malaysia Press 2023
Online Access:	http://psasir.upm.edu.my/id/eprint/106859/

Similar Items

MPTP-induced mouse model of Parkinson’s disease: a promising direction for therapeutic strategies
by: Mustapha, Musa, et al.
Published: (2021)

Possible epigenetic role of vitexin in regulating neuroinflammation in Alzheimer’s disease
by: Yahaya, Muhamad Afiq Faisal, et al.
Published: (2020)

MPTP- induced BALB/C mice recapitulate compensatory Parkinson’s-like motor features
by: Musa Mustapha,, et al.
Published: (2024)

MPTP- induced Balb/c mice recapitulate compensatory Parkinson’s-like motor features
by: Mustapha, Musa, et al.
Published: (2024)

Application of Ultrasound on the Extraction of Vitexin from Ficus Deltoidea Leaves
by: Nur Aimi Syairah , Mohd Abdul Alim, et al.
Published: (2016)

The unified parkinson's disease rating scale score in parkinson's disease patients with and without cognitive impairment
by: Hilmi, Abdullah
Published: (2007)

Treatment of depression and anxiety in Parkinson’s Disease
by: Troeung, Lakkhina
Published: (2013)

The Measurement and Nature of Impulsivity in Parkinson’s disease
by: Booth, Leon David
Published: (2020)

Application of neural networks in early detection and diagnosis of parkinson's disease
by: Olanrewaju, Rashidah Funke, et al.
Published: (2014)

Vitexin promotes nitric oxide production in human umbilical vein endothelial cells
by: Azizah Ugusman,, et al.
Published: (2025)

Ultrasound and enzymatic mediated extraction of vitexin and isovitexin from ficus deltoidea leaves
by: Nur Aima Syairah, Mohd Abdul Alim
Published: (2017)

Transgenic nematodes as a model for Parkinson’s disease
by: Bodhicharla, Rakesh Kumar
Published: (2012)

Analysis of mitochondrial haemoglobin in Parkinson's disease brain
by: Shephard, Freya, et al.
Published: (2016)

Literature Review on Acupuncture Treatment for Parkinson’s Disease
by: Teng, Le-xus, et al.
Published: (2024)

Intelligent glove for suppression of resting tremor in parkinson’s disease
by: M. Zulkefli, Adibah, et al.
Published: (2019)

Limbic grey matter changes in early Parkinson's disease
by: Li, Xingfeng, et al.
Published: (2017)

Nonpharmacological Interventions for Mild Cognitive Impairment in Parkinson’s Disease
by: Lawrence, Blake Justin
Published: (2016)

A Bayesian Evaluation of Subtyping Methods in Parkinson’s Disease
by: Johnson, Andrew Robert
Published: (2019)

Factor Structure of the Ways of Coping Questionnaire in Parkinson's Disease
by: Corti, E., et al.
Published: (2018)

Motor Heterogeneity in Parkinson's Disease: A Bayesian Perspective
by: Johnson, A., et al.
Published: (2017)

Cognitive reserve, executive function, and memory in parkinson’s disease
by: Loftus, Andrea, et al.
Published: (2021)

Predicting Parkinson’s Disease Using Machine Learning Model
by: Sanjay Aswath, K.S.M, et al.
Published: (2024)

Suitability of the depression, anxiety, and stress scale in Parkinson's disease
by: Johnson, A., et al.
Published: (2016)

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
by: Lawrence, B., et al.
Published: (2016)

Validity of driving simulator in assessing drivers with Parkinson's Disease
by: Lee, Hoe, et al.
Published: (2008)

Cognitive behaviour therapy for depression and anxiety in Parkinson's disease
by: Egan, Sarah, et al.
Published: (2015)

Beneficial collaboration
by: Ong, Han Sean
Published: (2017)

Beneficial partnership.
by: The Star, Alycia Lim
Published: (2011)

Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
by: Salama, Mohamed, et al.
Published: (2018)

Physiotherapy and occupational therapy and mild to moderate Parkinson Disease — Reply
by: Clarke, Carl E., et al.
Published: (2016)

Insights into Parkinson’s disease from computational models of the basal ganglia
by: Humphries, Mark D., et al.
Published: (2018)

Insights into Parkinson’s disease from computational models of the basal ganglia
by: Humphries, Mark D., et al.
Published: (2018)

Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease
by: Reyes, S., et al.
Published: (2013)

Improving assessment methods for freezing of gait in people with Parkinson’s disease
by: Scully, Aileen Eugenia
Published: (2022)

Environmental risk factors of Parkinson’s disease: a scoping review
by: Faeiz Syezri Adzmin Jaafar,, et al.
Published: (2024)

Would people with Parkinson's disease benefit from palliative care?
by: Hudson, P., et al.
Published: (2006)

Activities of Daily Living, Depression, and Quality of Life in Parkinson’s Disease
by: Lawrence, B., et al.
Published: (2014)

Coping processes and health-related quality of life in Parkinson’s disease
by: Bucks, R., et al.
Published: (2011)

Driving assessment in Parkinson's disease - A novel predictor of performance?
by: Cordell, Richard, et al.
Published: (2008)

Parkinson’s Disease - A review on treatment strategies and its advances
by: Subashini, Raman, et al.
Published: (2020)